Document is current
Any future updates will be listed below
-
Authors
Wang, Hanchen https://orcid.org/0000-0002-1691-024X
Leskovec, Jure https://orcid.org/0000-0002-5411-923X
Regev, Aviv https://orcid.org/0000-0003-3293-3158
- License Information
-
More Information
Article History
Received: 2 April 2024
Accepted: 8 May 2025
First Online: 11 June 2025
Competing interests
: H.W. and A.R. are employees of Genentech, a member of the Roche Group. A.R. has equity in Roche. A.R. is a cofounder and equity holder of Celsius Therapeutics and is an equity holder in Immunitas. Until 31 July 2020, A.R. was a scientific advisory board member of Thermo Fisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov. A.R. is a named inventor on multiple filed patents related to single-cell and spatial genomics, including for scRNA-seq, spatial transcriptomics, Perturb-Seq, compressed experiments and PerturbView.
